The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Medtronic PLC

NYSE: MDT
Last

(U.S.) $77.38

Today's change+0.77 +1.01%
Updated March 27 4:01 PM EDT. Delayed by at least 15 minutes.
 

Medtronic PLC

NYSE: MDT
Last

(U.S.) $77.38

Today's change+0.77 +1.01%
Updated March 27 4:01 PM EDT. Delayed by at least 15 minutes.

Medtronic PLC up (U.S.)$0.77

Medtronic PLC closed up Friday by (U.S.)$0.77 or 1.01% to (U.S.)$77.38. Shares have lost 0.82% over the last five days, but sit 2.67% below their 52-week high. This security has outperformed the S&P 500 by 19.31% during the last year.

Key company metrics

  • Open(U.S.) $76.54
  • Previous close(U.S.) $76.61
  • High(U.S.) $77.60
  • Low(U.S.) $76.50
  • Bid / Ask-- / --
  • YTD % change+7.17%
  • Volume4,510,282
  • Average volume (10-day)6,104,874
  • Average volume (1-month)5,898,818
  • Average volume (3-month)8,340,051
  • 52-week range(U.S.) $55.85 to (U.S.) $79.50
  • Beta1.08
  • Trailing P/E24.77×
  • P/E 1 year forward17.61×
  • Forward PEG2.16×
  • Indicated annual dividend(U.S.) $1.22
  • Dividend yield1.58%
  • Trailing EPS(U.S.) $3.12
Updated March 27 4:01 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+17.83%

Based on its net profit margin of 17.83%, Medtronic PLC is less effective than other companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.39%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJan 23, 201501/23/2015Oct 24, 201410/24/2014Jul 25, 201407/25/2014Apr 25, 201404/25/2014
Revenue4,3184,3664,2734,565
Total other revenue--------
Total revenue4,3184,3664,2734,565
Gross profit3,1903,2243,1683,394
Total cost of revenue1,1281,1421,1051,171
Total operating expense2,8903,2553,1854,074
Selling / general / administrative1,4871,5071,5061,539
Research & development373374365385
Depreciation / amortization89898786
Interest expense (income), net operating--------
Unusual expense (income)-5816171834
Other operating expenses, total-129-185159
Operating income1,4281,1111,088491
Interest income (expense), net non-operating-176-94-97--
Gain (loss) on sale of assets--------
Other--------
Income before tax1,1941,0221,083481
Income after tax977828871448
Income tax, total21719421233
Net income977828871448
Total adjustments to net income--------
Net income before extra. items977828871448
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items977828871448
Inc. avail. to common incl. extra. items977828871448
Diluted net income977828871448
Dilution adjustment0------
Diluted weighted average shares9969931,0051,012
Diluted EPS excluding extraordinary itemsvalue per share0.980.830.870.44
Dividends per sharevalue per share0.310.310.310.28
Diluted normalized EPSvalue per share0.960.940.911.21